| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |